{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:04:28Z","timestamp":1772510668571,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has changed the clinical day-to-day practice. The aim of this study was to evaluate the impact of the pandemic on patients with high-grade glioma (HGG) as well as to derive best practice recommendations. We compared a multi-institutional cohort with HGG (n\u2009=\u2009251) from 03\/2020 to 05\/2020 (n\u2009=\u2009119) to a historical cohort from 03\/2019 to 05\/2019 (n\u2009=\u2009132). The endpoints were outcome (progression-free survival (PFS) and overall survival (OS)) as well as patterns of care and time intervals between treatment steps. The median OS for WHO grade 4 gliomas was 12\u00a0months in 2019 (95% Confidence Interval 9.7\u201314.3\u00a0months), and not reached in 2020 (<jats:italic>p<\/jats:italic>\u2009=\u2009.026). There were no other significant differences in the Kaplan\u2013Meier estimates for OS and PFS between cohorts of 2019 and 2020, neither did stratification by WHO grade reveal any significant differences for OS, PFS or for patterns of care. The time interval between cranial magnetic resonance imaging (cMRI) and biopsy was significantly longer in 2020 cohort (11 versus 21\u00a0days, <jats:italic>p<\/jats:italic>\u2009=\u2009.031). Median follow-up was 10\u00a0months (range 0\u201330\u00a0months). Despite necessary disease containment policies, it is crucial to ensure that patients with HGG are treated in line with the recent guidelines and standard of care (SOC) algorithms. Therefore, we strongly suggest pursuing no changes to SOC treatment, a timely diagnosis and treatment with short time intervals between first symptoms, initial diagnosis, and treatment, as well as a guideline-based cMRI follow-up.<\/jats:p>","DOI":"10.1038\/s41598-023-29790-8","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T10:03:16Z","timestamp":1676541796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations"],"prefix":"10.1038","volume":"13","author":[{"given":"Marco M. E.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Gempt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Krenzlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zeyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Nettekoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammam","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veit","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Goldbrunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim P.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"29790_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269. https:\/\/doi.org\/10.1038\/s41586-020-2008-3 (2020).","journal-title":"Nature"},{"key":"29790_CR2","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.2147\/cmar.S318115","volume":"13","author":"S Dhada","year":"2021","unstructured":"Dhada, S., Stewart, D., Cheema, E., Hadi, M. A. & Paudyal, V. Cancer services during the COVID-19 pandemic: systematic review of patient\u2019s and Caregiver\u2019s experiences. Cancer Manag. Res. 13, 5875\u20135887. https:\/\/doi.org\/10.2147\/cmar.S318115 (2021).","journal-title":"Cancer Manag. Res."},{"key":"29790_CR3","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.dscb.2021.100012","volume":"2","author":"MA Azab","year":"2021","unstructured":"Azab, M. A. & Azzam, A. Y. Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review. Brain Disord. 2, 100012\u2013100012. https:\/\/doi.org\/10.1016\/j.dscb.2021.100012 (2021).","journal-title":"Brain Disord."},{"key":"29790_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa113","author":"D Bernhardt","year":"2020","unstructured":"Bernhardt, D. et al. Neuro-oncology management during the COVID-19 pandemic with a focus on WHO Grade III and IV Gliomas. Neuro. Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaa113 (2020).","journal-title":"Neuro. Oncol."},{"key":"29790_CR5","first-page":"14","volume":"81","author":"World Medical Association Declaration of Helsinki","year":"2014","unstructured":"World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. J. Am. Coll. Dent. 81, 14\u201318 (2014).","journal-title":"J. Am. Coll. Dent."},{"key":"29790_CR6","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/s1470-2045(14)70011-7","volume":"15","author":"M Weller","year":"2014","unstructured":"Weller, M. et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15, e395-403. https:\/\/doi.org\/10.1016\/s1470-2045(14)70011-7 (2014).","journal-title":"Lancet Oncol"},{"key":"29790_CR7","unstructured":"Wick, W. & al., e. Gliome, S2k-Leitlinie, < www.dgn.org\/leitlinien > (2021)."},{"key":"29790_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller, M. et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat. Rev. Clin. Oncol. 18, 170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"29790_CR9","doi-asserted-by":"publisher","unstructured":"Warren, K. T. et al. Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study. CNS Oncol. 9, Cns64, doi:https:\/\/doi.org\/10.2217\/cns-2020-0018 (2020).","DOI":"10.2217\/cns-2020-0018"},{"key":"29790_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/0284186x.2019.1672893","volume":"59","author":"M Potharaju","year":"2020","unstructured":"Potharaju, M., Mathavan, A., Mangaleswaran, B., Ghosh, S. & John, R. Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients. Acta Oncol. (Stockholm, Sweden) 59, 320\u2013323. https:\/\/doi.org\/10.1080\/0284186x.2019.1672893 (2020).","journal-title":"Acta Oncol. (Stockholm, Sweden)"},{"key":"29790_CR11","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1016\/j.wneu.2019.09.122","volume":"133","author":"S Ahn","year":"2020","unstructured":"Ahn, S., Park, J. S., Song, J. H., Jeun, S. S. & Hong, Y. K. Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: a single-institution study with subgroup analysis according to the extent of tumor resection. World Neurosurg. 133, e640\u2013e645. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.122 (2020).","journal-title":"World Neurosurg."},{"key":"29790_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/02688697.2015.1012050","volume":"29","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal, A. et al. Diagnostic delay and survival in high-grade gliomas - evidence of the \u201cwaiting time paradox\u201d?. Br. J. Neurosurg. 29, 520\u2013523. https:\/\/doi.org\/10.3109\/02688697.2015.1012050 (2015).","journal-title":"Br. J. Neurosurg."},{"key":"29790_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/02688697.2018.1436693","volume":"32","author":"M Kosmin","year":"2018","unstructured":"Kosmin, M. et al. The impact of route of diagnosis on survival in patients with glioblastoma. Br. J. Neurosurg. 32, 628\u2013630. https:\/\/doi.org\/10.1080\/02688697.2018.1436693 (2018).","journal-title":"Br. J. Neurosurg."},{"key":"29790_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rpor.2018.09.003","volume":"24","author":"JS Marra","year":"2019","unstructured":"Marra, J. S. et al. Survival after radiation therapy for high-grade glioma. Rep. Pract. Oncol. Radiother. 24, 35\u201340. https:\/\/doi.org\/10.1016\/j.rpor.2018.09.003 (2019).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"29790_CR15","doi-asserted-by":"publisher","unstructured":"Gandhi, S. et al. Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid\u2013guided surgery: a systematic review and meta-analysis. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00620 (2019).","DOI":"10.3389\/fonc.2019.00620"},{"key":"29790_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jcms.2020.03.011","volume":"48","author":"M Zimmermann","year":"2020","unstructured":"Zimmermann, M. & Nkenke, E. Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic. J. Cranio-Max.-Fac. Surg. 48, 521\u2013526. https:\/\/doi.org\/10.1016\/j.jcms.2020.03.011 (2020).","journal-title":"J. Cranio-Max.-Fac. Surg."},{"key":"29790_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.eururo.2020.03.027","volume":"77","author":"KD Stensland","year":"2020","unstructured":"Stensland, K. D. et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur. Urol. 77, 663\u2013666. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.027 (2020).","journal-title":"Eur. Urol."},{"key":"29790_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijsu.2020.05.061","volume":"79","author":"L Moletta","year":"2020","unstructured":"Moletta, L. et al. International guidelines and recommendations for surgery during Covid-19 pandemic: a systematic review. Int. J. Surg. (Lond., Engl.) 79, 180\u2013188. https:\/\/doi.org\/10.1016\/j.ijsu.2020.05.061 (2020).","journal-title":"Int. J. Surg. (Lond., Engl.)"},{"key":"29790_CR19","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s11605-020-04712-5","volume":"24","author":"SC Fligor","year":"2020","unstructured":"Fligor, S. C. et al. Gastrointestinal malignancies and the COVID-19 pandemic: evidence-based triage to surgery. J. Gastrointest. Surg. 24, 2357\u20132373. https:\/\/doi.org\/10.1007\/s11605-020-04712-5 (2020).","journal-title":"J. Gastrointest. Surg."},{"key":"29790_CR20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/pm\/pnaa127","volume":"21","author":"SP Cohen","year":"2020","unstructured":"Cohen, S. P. et al. Pain management best practices from multispecialty organizations during the COVID-19 pandemic and public health crises. Pain Med 21, 1331\u20131346. https:\/\/doi.org\/10.1093\/pm\/pnaa127 (2020).","journal-title":"Pain Med"},{"key":"29790_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3171\/2008.4.17536","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt, M. J. et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J. Neurosurg. 110, 156\u2013162. https:\/\/doi.org\/10.3171\/2008.4.17536 (2009).","journal-title":"J. Neurosurg."},{"key":"29790_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459\u2013466. https:\/\/doi.org\/10.1016\/s1470-2045(09)70025-7 (2009).","journal-title":"Lancet Oncol"},{"key":"29790_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0167-8140(02)00078-6","volume":"64","author":"N Laperriere","year":"2002","unstructured":"Laperriere, N., Zuraw, L. & Cairncross, G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother. Oncol. 64, 259\u2013273. https:\/\/doi.org\/10.1016\/s0167-8140(02)00078-6 (2002).","journal-title":"Radiother. Oncol."},{"key":"29790_CR24","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp, R. et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314, 2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669 (2015).","journal-title":"JAMA"},{"key":"29790_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/neuros\/nyx084","volume":"81","author":"PM Flanigan","year":"2017","unstructured":"Flanigan, P. M. et al. Improved survival with decreased wait time to surgery in glioblastoma patients presenting with seizure. Neurosurgery 81, 824\u2013833. https:\/\/doi.org\/10.1093\/neuros\/nyx084 (2017).","journal-title":"Neurosurgery"},{"key":"29790_CR26","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1038\/s41598-020-61701-z","volume":"10","author":"SM Buszek","year":"2020","unstructured":"Buszek, S. M. et al. Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the national cancer database. Sci. Rep. 10, 4926. https:\/\/doi.org\/10.1038\/s41598-020-61701-z (2020).","journal-title":"Sci. Rep."},{"key":"29790_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12879-022-07128-5","volume":"22","author":"NK Ngandu","year":"2022","unstructured":"Ngandu, N. K. et al. Hospital acquired COVID-19 infections amongst patients before the rollout of COVID-19 vaccinations, a scoping review. BMC Infect. Dis. 22, 140. https:\/\/doi.org\/10.1186\/s12879-022-07128-5 (2022).","journal-title":"BMC Infect. Dis."},{"key":"29790_CR28","doi-asserted-by":"publisher","unstructured":"Thompson, G., Lawrie, T. A., Kernohan, A., Jenkinson, M. D. Interval brain imaging for adults with cerebral glioma. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD013137.pub2 (2019).","DOI":"10.1002\/14651858.CD013137.pub2"},{"key":"29790_CR29","unstructured":"National Comprehensive Cancer Network. Central Nervous System Cancers (Version 2.2021), https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf (2021)."},{"key":"29790_CR30","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/s1470-2045(17)30194-8","volume":"18","author":"M Weller","year":"2017","unstructured":"Weller, M. et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 18, e315\u2013e329. https:\/\/doi.org\/10.1016\/s1470-2045(17)30194-8 (2017).","journal-title":"Lancet Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29790-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29790-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:12:34Z","timestamp":1676545954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29790-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29790-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ulrich Herrlinger has received lecture and\/or advisory board honoraria from Medac, Bayer, Janssen, and Karyopharm. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2766"}}